Tenet Healthcare Stock Price Target and Analyst Ratings (NYSE:THC)

Analyst Price Target for THC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$41.47

▼ -16.66% Downside Potential

This price target is based on 14 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $41.47, with a high forecast of $60.00 and a low forecast of $20.00. The average price target represents a -16.66% upside from the last price of $49.76.

Buy

The current consensus among 14 investment analysts is to buy stock in Tenet Healthcare. This rating has held steady since July 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

8/5/2019

0 strong buy ratings
7 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

11/3/2019

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

2/1/2020

0 strong buy ratings
5 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

5/1/2020

0 strong buy ratings
6 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

7/30/2020

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

10/28/2020

0 strong buy ratings
7 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

12/27/2020

0 strong buy ratings
9 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

1/26/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
1/21/2021	UBS Group	Boost Price Target	Positive ➝ Buy	$37.00 ➝ $60.00	High	i
1/14/2021	Raymond James	Boost Price Target	Outperform	$55.00 ➝ $60.00	High	i
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$27.00 ➝ $60.00	Low	i
1/5/2021	Bank of America	Upgrade	Neutral ➝ Buy	$45.00 ➝ $50.00	N/A	i
12/18/2020	Mizuho	Boost Price Target	Buy	$32.00 ➝ $48.00	Medium	i
12/15/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy		Medium	i
12/11/2020	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target		$33.00 ➝ $50.00	Medium	i
12/11/2020	Smith Barney Citigroup	Boost Price Target		$33.00 ➝ $50.00	High	i
12/11/2020	Credit Suisse Group	Boost Price Target	Outperform	$39.00 ➝ $48.00	Medium	i
12/11/2020	Barclays	Boost Price Target	Equal Weight	$28.00 ➝ $46.00	High	i
11/11/2020	Piper Sandler	Boost Price Target	Neutral	$31.00 ➝ $36.00	High	i
11/9/2020	Mizuho	Boost Price Target	Buy	$30.00 ➝ $32.00	High	i
10/22/2020	Raymond James	Boost Price Target	Outperform	$40.00 ➝ $43.00	High	i
9/21/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$28.00 ➝ $20.00	High	i
9/4/2020	Royal Bank of Canada	Boost Price Target		$30.00 ➝ $35.00	Low	i
8/14/2020	Truist	Boost Price Target		$21.00 ➝ $30.00	Medium	i
8/10/2020	UBS Group	Boost Price Target	Buy	$30.00 ➝ $35.00	Low	i
8/5/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$25.00 ➝ $28.00	High	i
8/4/2020	Credit Suisse Group	Reiterated Rating	Buy		High	i
6/11/2020	UBS Group	Lower Price Target	Buy	$32.00 ➝ $30.00	High	i
5/29/2020	Mizuho	Lower Price Target	Buy	$32.00 ➝ $30.00	High	i
5/21/2020	SunTrust Banks	Boost Price Target	Hold	$22.00 ➝ $25.00	Medium	i
5/20/2020	Citigroup	Lower Price Target	Buy	$35.00 ➝ $27.00	High	i
5/14/2020	UBS Group	Lower Price Target	Buy	$49.00 ➝ $32.00	High	i
5/11/2020	Barclays	Boost Price Target	Equal Weight	$19.00 ➝ $22.00	Low	i
5/6/2020	Credit Suisse Group	Reiterated Rating	Buy	$33.00	Low	i
5/6/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$40.00 ➝ $32.00	Low	i
5/6/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$31.00 ➝ $25.00	High	i
4/13/2020	SunTrust Banks	Boost Price Target	Hold	$18.00 ➝ $22.00	Low	i
4/13/2020	Royal Bank of Canada	Reiterated Rating	Buy	$26.00	Medium	i
4/3/2020	SunTrust Banks	Lower Price Target	Hold	$42.00 ➝ $18.00	High	i
3/25/2020	Barclays	Reiterated Rating	Hold	$19.00	High	i
3/11/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$32.00 ➝ $39.00	High	i
2/26/2020	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$31.00 ➝ $32.00	High	i
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$20.00	Low	i
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Underweight	$23.00 ➝ $31.00	Medium	i
12/18/2019	SunTrust Banks	Boost Price Target	Hold	$31.00 ➝ $42.00	Medium	i Rating by David S Macdonald at SunTrust Banks, Inc.
12/9/2019	UBS Group	Upgrade	Neutral ➝ Buy	$24.00 ➝ $53.00	High	i
11/7/2019	Mizuho	Reiterated Rating	Buy		Low	i
11/6/2019	Mizuho	Boost Price Target		$30.00 ➝ $33.00	Low	i
11/6/2019	SunTrust Banks	Boost Price Target	Hold	$24.00 ➝ $31.00	High	i Rating by David S Macdonald at SunTrust Banks, Inc.
11/6/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$25.00 ➝ $36.00	High	i
8/14/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$28.00 ➝ $28.00	High	i
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold	$26.00	Medium	i
8/7/2019	SunTrust Banks	Set Price Target	Hold	$24.00	Low	i Rating by David S Macdonald at SunTrust Banks, Inc.
5/1/2019	SunTrust Banks	Lower Price Target	Hold	$27.00	High	i
4/17/2019	Barclays	Set Price Target	Hold	$24.00	Medium	i Rating by Steven Valiquette at Barclays PLC
2/27/2019	Raymond James	Boost Price Target		$37.00 ➝ $47.00	Medium	i
2/27/2019	Citigroup	Boost Price Target	Buy ➝ Buy	$35.00 ➝ $37.00	High	i
2/26/2019	Bank of America	Reiterated Rating	Neutral ➝ Neutral	$21.00 ➝ $30.00	High	i
1/28/2019	Mizuho	Reiterated Rating	Buy	$28.00	Low	i Rating by Ann Hynes at Mizuho
1/14/2019	Stephens	Initiated Coverage	Equal ➝ Equal Weight	$23.00	Medium	i
1/6/2019	Barclays	Reiterated Rating	Hold	$20.00	High	i
1/3/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold ➝ Hold	$20.00	Low	i
12/17/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		High	i
12/3/2018	Raymond James	Reiterated Rating	Buy	$37.00	High	i
11/15/2018	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$26.00	Low	i
11/7/2018	Robert W. Baird	Reiterated Rating	Buy	$35.00	High	i
11/7/2018	Barclays	Reiterated Rating	Hold	$27.00	High	i
8/14/2018	Barclays	Initiated Coverage	Equal Weight	$35.00	Low	i
8/10/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$22.00 ➝ $28.00	Low	i
8/8/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$34.00	Medium	i
8/8/2018	SunTrust Banks	Reiterated Rating	Hold	$35.00	Medium	i
8/7/2018	Mizuho	Set Price Target	Buy	$36.00	Medium	i Rating by Ann Hynes at Mizuho
7/23/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$37.00 ➝ $44.00	High	i
6/29/2018	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$28.00 ➝ $38.00	Medium	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/9/2018	Mizuho	Reiterated Rating	Buy	$35.00	Medium	i Rating by Ann Hynes at Mizuho
5/8/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $37.00	Low	i
5/4/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$27.00 ➝ $33.00	Low	i
5/2/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$16.00 ➝ $24.00	High	i
5/2/2018	SVB Leerink	Boost Price Target	Outperform	$30.00 ➝ $40.00	High	i
4/17/2018	SunTrust Banks	Reiterated Rating	Hold	$27.00	Low	i
3/22/2018	Mizuho	Reiterated Rating	Buy	$29.00	High	i Rating by Sheryl Skolnick at Mizuho
3/5/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $18.00	Low	i
3/1/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$21.00	High	i
3/1/2018	SunTrust Banks	Reiterated Rating	Hold		High	i Rating by David S Macdonald at SunTrust Banks, Inc.
3/1/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $27.00	Low	i
2/28/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $16.00	Medium	i
2/28/2018	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$20.00 ➝ $22.00	High	i
2/28/2018	Raymond James	Upgrade	Market Perform ➝ Outperform	$30.00	High	i
2/27/2018	Jefferies Financial Group	Set Price Target	Buy	$23.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
1/30/2018	Wells Fargo & Company	Initiated Coverage	Market Perform ➝ Market Perform	$20.00	High	i
1/3/2018	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$15.00	High	i
12/20/2017	SVB Leerink	Reiterated Rating	Buy	$27.00	Low	i
12/20/2017	Morgan Stanley	Downgrade	Equal Weight ➝ Underweight	$14.00	Medium	i
12/19/2017	Mizuho	Boost Price Target	Neutral	$13.00 ➝ $15.00	High	i
12/14/2017	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$15.00	Medium	i
12/12/2017	Citigroup	Upgrade	Neutral ➝ Buy		High	i
11/21/2017	William Blair	Reiterated Rating	Market Perform		N/A	i Rating by M. Larew at William Blair
11/13/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$19.00 ➝ $17.00	N/A	i
11/10/2017	Mizuho	Reiterated Rating	Neutral ➝ Hold		N/A	i
11/9/2017	Morgan Stanley	Lower Price Target	Equal Weight	$15.00 ➝ $14.00	N/A	i
11/8/2017	SVB Leerink	Reiterated Rating	Outperform	$30.00 ➝ $25.00	N/A	i Rating by A. Gupte at SVB Leerink LLC
11/2/2017	Credit Suisse Group	Initiated Coverage	Neutral	$15.00	N/A	i
10/30/2017	Jefferies Financial Group	Set Price Target	Buy	$24.00 ➝ $20.00	N/A	i
10/15/2017	SunTrust Banks	Set Price Target	Hold	$15.00	N/A	i Rating by David S Macdonald at SunTrust Banks, Inc.
9/28/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	High	i
9/25/2017	Royal Bank of Canada	Reiterated Rating	Hold	$19.00	High	i
9/21/2017	Jefferies Financial Group	Reiterated Rating	Buy	$24.00	Low	i Rating by Sean Dodge at Jefferies Financial Group Inc.
9/14/2017	Mizuho	Reiterated Rating	Neutral	$14.00	Medium	i Rating by Sheryl Skolnick at Mizuho
9/14/2017	Citigroup	Reiterated Rating	Hold	$16.00	Medium	i
9/1/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$24.00	Low	i
8/24/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	Low	i
8/24/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Low	i
8/20/2017	Mizuho	Reiterated Rating	Neutral	$14.00	High	i Rating by Sheryl Skolnick at Mizuho
8/20/2017	SVB Leerink	Reiterated Rating	Outperform	$23.00 ➝ $30.00	High	i Rating by A. Gupte at SVB Leerink LLC
8/10/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$28.00 ➝ $24.00	Low	i
8/10/2017	Citigroup	Reiterated Rating	Neutral	$20.00 ➝ $16.00	Medium	i
8/10/2017	Robert W. Baird	Reiterated Rating	Outperform	$23.00	Medium	i
8/9/2017	Credit Suisse Group	Lower Price Target	Neutral	$20.00 ➝ $17.00	Low	i
8/8/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$26.00 ➝ $24.00	High	i Rating by Sean Dodge at Jefferies Financial Group Inc.
7/18/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Medium	i
6/6/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$27.00	Medium	i Rating by A. Gupte at SVB Leerink LLC
6/6/2017	Morgan Stanley	Initiated Coverage	Equal ➝ Equal Weight	$19.00	High	i
6/6/2017	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$22.00	Low	i
5/15/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Medium	i
5/5/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Low	i
4/29/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00 ➝ $26.00	Low	i Rating by Sean Dodge at Jefferies Financial Group Inc.
4/23/2017	Mizuho	Reiterated Rating	Neutral	$18.00	Low	i Rating by Sheryl Skolnick at Mizuho
4/13/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00	Low	i
4/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$28.00	High	i
3/27/2017	Mizuho	Lower Price Target	Neutral	$22.50 ➝ $18.00	High	i Rating by Sheryl Skolnick at Mizuho
3/6/2017	Citigroup	Lower Price Target	Neutral	$22.00 ➝ $20.00	N/A	i
3/3/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	N/A	i
2/24/2017	Mizuho	Upgrade	Underperform ➝ Neutral	$13.00 ➝ $22.80	N/A	i Rating by Sheryl Skolnick at Mizuho
2/6/2017	Jefferies Financial Group	Lower Price Target	Buy	$36.00 ➝ $28.00	N/A	i
1/24/2017	SVB Leerink	Reiterated Rating	Market Perform	$22.00	N/A	i Rating by ana gupte at SVB Leerink LLC
1/11/2017	UBS Group	Reiterated Rating	Buy	$26.00 ➝ $24.00	N/A	i
1/3/2017	Piper Jaffray Companies	Initiated Coverage	Neutral	$16.00	N/A	i
11/22/2016	Mizuho	Downgrade	Neutral ➝ Underperform	$13.00	N/A	i Rating by Sheryl Skolnick at Mizuho
11/10/2016	Raymond James	Downgrade	Outperform ➝ Market Perform		N/A	i
11/10/2016	UBS Group	Downgrade	Outperform ➝ Market Perform		N/A	i Rating by A.J. Rice at UBS Group AG
11/9/2016	Bank of America	Downgrade	Buy ➝ Neutral	$32.00 ➝ $25.00	N/A	i
10/25/2016	Wolfe Research	Initiated Coverage	Market Perform		N/A	i
10/5/2016	Mizuho	Lower Price Target	Neutral	$28.00 ➝ $22.00	N/A	i Rating by Sheryl Skolnick at Mizuho
9/4/2016	SVB Leerink	Reiterated Rating	Market Perform	$30.00 ➝ $28.00	N/A	i Rating by Ana Gupte at SVB Leerink LLC
8/22/2016	UBS Group	Reiterated Rating	Buy		N/A	i Rating by A.J. Rice at UBS Group AG
8/19/2016	Barclays	Reiterated Rating	Buy	$39.00	N/A	i Rating by Joshua Raskin at Barclays PLC
8/4/2016	Citigroup	Lower Price Target	Neutral	$36.00 ➝ $31.00	N/A	i
8/2/2016	Morgan Stanley	Reiterated Rating	Hold	$38.00	N/A	i Rating by Andrew Schenker at Morgan Stanley
8/2/2016	Mizuho	Reiterated Rating	Neutral	$33.00 ➝ $28.00	N/A	i Rating by Sheryl Skolnick at Mizuho
7/11/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A	i
6/28/2016	Credit Suisse Group	Reiterated Rating	Hold		N/A	i Rating by Scott Fidel at Credit Suisse Group AG
6/13/2016	LADENBURG THALM/SH SH	Upgrade	Not Rated ➝ Underperform		N/A	i
5/24/2016	UBS Group	Reiterated Rating	Buy	$48.00	N/A	i Rating by A.J. Rice at UBS Group AG
5/16/2016	Sterne Agee CRT	Reiterated Rating	Buy		N/A	i Rating by B. Wright at Sterne Agee CRT
5/16/2016	Robert W. Baird	Reiterated Rating	Buy		N/A	i Rating by Whit Mayo at Robert W. Baird
5/5/2016	JPMorgan Chase & Co.	Reiterated Rating	Hold	$36.00	N/A	i
5/4/2016	Citigroup	Boost Price Target	Neutral	$27.00 ➝ $36.00	N/A	i
5/4/2016	Mizuho	Downgrade	Buy ➝ Neutral	$33.00	N/A	i Rating by Sheryl Skolnick at Mizuho
5/3/2016	Bank of America	Reiterated Rating	Buy		N/A	i Rating by Kevin Fischbeck at Bank of America Co.
5/3/2016	Morgan Stanley	Reiterated Rating	Hold		N/A	i Rating by Andrew Schenker at Morgan Stanley
5/3/2016	Credit Suisse Group	Reiterated Rating	Hold	$31.00	N/A	i Rating by Ralph Giacobbe at Credit Suisse Group AG
5/2/2016	SVB Leerink	Reiterated Rating	Hold		N/A	i Rating by Ana Gupte at SVB Leerink LLC
4/13/2016	140166	Upgrade	Neutral ➝ Positive	$38.00	N/A	i
3/24/2016	Credit Suisse Group	Boost Price Target	Neutral	$30.00 ➝ $31.00	N/A	i Rating by Ralph Giacobbe at Credit Suisse Group AG
3/16/2016	Mizuho	Boost Price Target	Buy	$30.00 ➝ $33.00	N/A	i Rating by Sheryl Skolnick at Mizuho
3/7/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$37.00 ➝ $30.00	N/A	i
3/2/2016	SVB Leerink	Reiterated Rating	Market Perform	$36.00 ➝ $30.00	N/A	i
2/26/2016	140166	Lower Price Target		$30.00 ➝ $23.00	N/A	i
2/26/2016	BMO Capital Markets	Lower Price Target	Outperform	$55.00 ➝ $38.00	N/A	i Rating by Jennifer Lynch at BMO Capital Markets
2/25/2016	UBS Group	Reiterated Rating	Buy	$51.00 ➝ $48.00	N/A	i Rating by A.J. Rice at UBS Group AG
2/24/2016	SunTrust Banks	Lower Price Target	Neutral	$34.00 ➝ $28.00	N/A	i
2/24/2016	Barclays	Reiterated Rating	Buy	$42.00 ➝ $34.00	N/A	i Rating by Joshua Raskin at Barclays PLC
2/23/2016	Credit Suisse Group	Lower Price Target	Neutral	$33.00 ➝ $30.00	N/A	i Rating by Ralph Giacobbe at Credit Suisse Group AG

(Data available from 1/27/2016 forward)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical, off-campus emergency, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2019, the company operated 65 hospitals, 24 surgical hospitals, and approximately 159 outpatient centers, as well as 260 ambulatory surgery, 39 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

Today's Range

Now: $49.76

$49.46

$50.59

50 Day Range

MA: $43.07

$34.30

$50.74

52 Week Range

Now: $49.76

$10.00

$51.05

Volume

1,051,991 shs

Average Volume

1,026,790 shs

Market Capitalization

$5.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Piper Sandler, Raymond James, Royal Bank of Canada, Smith Barney Citigroup, SunTrust Banks, Inc., Truist, UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Tenet Healthcare?

17 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $41.47, suggesting a possible downside of 16.7%. UBS Group AG has the highest price target set, predicting THC will reach $60.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $20.00 for Tenet Healthcare in the next year.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 1 sell rating, 4 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.

What other companies compete with Tenet Healthcare?

Other companies that are similar to Tenet Healthcare include HCA Healthcare, Alcon, Universal Health Services, The Ensign Group, Acadia Healthcare, Select Medical, U.S. Physical Therapy, Community Health Systems, National HealthCare, Brookdale Senior Living, Five Star Senior Living, Capital Senior Living and Encompass Health.

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is 469-893-2200 and its investor relations email address is [email protected]th.com. The official website for Tenet Healthcare is www.tenethealth.com.

NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

Analyst Price Target for THC

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

What is the current price target for Tenet Healthcare?

What is the current consensus analyst rating for Tenet Healthcare?

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?